FEATURED EDITORIAL
Understanding the full scope of the life science industry has never been more critical. Ray Dogum, Chief Editor of Drug Discovery Online, joins the Life Science Connect Editors’ Roundtable on a special episode of Better Biopharma podcast.
- Engineering Therapeutics With A Structural Approach
- Room For Improvement: Reformulating Existing Therapeutics
- Harnessing Mitochondria: A New Frontier In Therapeutic Innovation
- The Unlikely Weapon Against Fentanyl: Your Immune System
- Partnering For Progress: Funding The Future Of Rare Disease Research
- In Vivo LNP-Engineered Cytokine-Armored CAR Cells For Solid Tumors
- Small Molecule Enzyme Mimetics In Age-Related Neurodegeneration
FEATURED APPLICATION CONTENT
-
Discover how mixed-mode chromatography enables high-yield purification of single-domain antibodies under mild conditions and why these approaches outperform traditional resins.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.
-
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.
-
Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.
-
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
-
Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.
-
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
- Annual Reflections And Predictions From The Editors' Roundtable
- The Unlikely Weapon Against Fentanyl: Your Immune System
- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
- GO‑4 Drug Combo Offers New Hope for Treating Late-Stage BRCA/PALB2-Mutated Cancers
- From Funding Gaps to AI Frontiers: Insights from the Boston Globe Summit 2025
FEATURED NEWS HEADLINES
- Basilea And Prokaryotics Enter Collaboration To Develop A Novel Broad-Spectrum Antifungal For The Treatment Of Severe Invasive Infections
- Headlamp Health Launches Lumos AI To De-Risk Neuroscience Drug Development
- BostonGene And Astrazeneca Announce Strategic Collaboration To Advance Foundation Model-Driven Oncology Development
- Novoron Bioscience Awarded $2.5M NIH/NIA SBIR Grant To Accelerate Alzheimer's Drug Discovery With Human Brain Organoids
- Variant Bio Launches Inference, The World's First Agentic AI Genomic Drug Discovery Platform
- YD Bio Enters Into MOU To Merge With EG BioMed, Advancing DNA Methylation–Driven AI Platforms For Cancer Diagnostics And Drug Development
- Biosplice Announces The Submission Of Its New Drug Application (NDA) To The FDA For Lorecivivint (LOR) To Treat Knee Osteoarthritis
- Ascentage Pharma Announces IND Clearance By The U.S. Food And Drug Administration For BTK Degrader APG-3288
- Kelun-Biotech Receives Investigational New Drug Approval For ITGB6-Targeted ADC SKB105 From The NMPA
- Insilico Medicine Announce US$888M Multi-Year Collaboration With Servier For Drug Discovery And Development In Oncology
ARCHIVED NEWSLETTER
- 01.06.26 -- The Unlikely Weapon Against Fentanyl: Your Immune System
- 12.23.25 -- 2025's Top 5 Drug Discovery Highlights And How To Stay Ahead In 2026
- 12.16.25 -- Returning To Nature: Discovering The Next Generation Of Medicines
- 12.09.25 -- When Preclinical Models Distort The Patient
- 12.01.25 -- Better Outcomes, Faster: PBPK Modeling For Absorption & Solid Form Security